Zoetis published its 2025 Sustainability Report, highlighting progress achieved in 2025 through its Driven to Care strategy. This report marks a significant milestone as Zoetis delivers on its initial aspirations set in 2021 and introduces its next phase with renewed focus across Communities, Animals, and the Planet.
Formalized in 2021, the Zoetis Driven to Care sustainability strategy was built on the company’s purpose to nurture our world and humankind by advancing care for animals. As Zoetis enters its next chapter of Driven to Care, the company is sharpening its strategic priorities to focus on the areas where it can have the greatest impact. This streamlined approach prioritizes advancing opportunities for colleagues and communities, solving sustainability challenges through innovation, and protecting the planet by embedding solutions for climate, waste, and nature.
“At Zoetis, we’re leading with purpose—turning Driven to Care into measurable impact for Communities, Animals, and the Planet through innovation, partnership, and global execution,” said Jeannette Ferran Astorga, Executive Vice President, Corporate Affairs, and Chief Sustainability Officer of Zoetis. “As we celebrate the achievement of our first set of aspirations and targets, we are proud of what our colleagues, partners, and communities have accomplished together, and with renewed purpose and refreshed focus, we look forward to building on this progress in the years to come.”
Highlights from the report reflecting progress attained in 2025 and since Driven to Care was introduced in 2021 include:
Communities
- The Zoetis Foundation achieved its goal of distributing $35 million in grants from 2021–2025 to advance opportunities for veterinary professionals and livestock farmers, in addition to supporting humanitarian aid and a matching gifts program.
- From 2021–2025, the Zoetis Foundation provided $12.8 million in grants to support veterinary scholarships, impacting 2,200+ students.
- Colleagues reported more than 20,700 hours of volunteer time across our global markets in 2025 — 104% of the company’s stated goal — with more than 72,000 hours reported from 2021–2025.
Animals
- Advanced science-driven solutions to combat avian influenza by receiving conditional licenses for its H5N2 vaccine for poultry in both the U.S. and Canada, and a conditional license for its H5N2 vaccine for dairy cattle in the U.S.
- Received conditional approval from the U.S. FDA for Dectomax ® -CA1 Injectable for the prevention and treatment of New World screwworm larvae infestations in cattle. This approval was the first for a parasite control product to receive conditional approval for this purpose.
- Collaborated with the National Oceanic and Atmospheric Administration (NOAA) and The Marine Mammal Center, the world’s largest marine mammal hospital, on a USDA-authorized vaccine trial to help protect endangered Hawaiian monk seals from avian influenza.
Planet
- Reduced Scope 1 and 2 emissions by 29% since 2021, completing 100+ carbon reduction projects across manufacturing and R&D sites, including 37 projects in 2025 alone, that are expected to reduce annual energy use by approximately 53,000 gigajoules and prevent approximately 5,000 metric tons CO2e annually.
- Progressed toward the RE100 goal in 2025, covering 85% of the company’s global electricity demand from renewable sources 1, up from 80% in 2024.
- Implemented a single-size, dual-temperature shipper at two major U.S. distribution centers, enabling ambient and cold chain products to ship together in one box and reducing overall packaging materials across the distribution network.
For more detailed disclosures on the company’s sustainability programs, practices and policies, please download Zoetis’ 2025 Sustainability Report or visit www.zoetis.com/sustainability. Zoetis will continue to share its sustainability progress against its Driven to Care aspirations, and report annually.
About Zoetis
Zoetis is the world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceuticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com.
